Paul Hastings Advised Lenders in Goldman Sachs Alternatives' Acquisition of Synthon
December 19, 2024
December 19, 2024
LOS ANGELES, California, Dec. 19 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised the lenders in connection with the financing of Goldman Sachs Alternatives' acquisition of Synthon, a leading platform specialised in developing, manufacturing, and out-licensing complex generic medicines.
The private equity business at Goldman Sachs Alternatives will acquire a majority stake in Synthon from funds advised by BC Partners, which will continu . . .
Paul Hastings LLP advised the lenders in connection with the financing of Goldman Sachs Alternatives' acquisition of Synthon, a leading platform specialised in developing, manufacturing, and out-licensing complex generic medicines.
The private equity business at Goldman Sachs Alternatives will acquire a majority stake in Synthon from funds advised by BC Partners, which will continu . . .